Bristol Myers Squibb Co (BMY): stock score 50/100

Bristol Myers Squibb Co (BMY) scores 50 out of 100 (around average among 99 US stocks) on trend, stability, fundamentals, market backdrop and news tone. Every calculation step shown. Educational, not advice.

BMY scores 49.5 out of 100 (around average), up 6.7 points from last week. Its price trend adds the most (+3.7 points: price is +4.0% vs its 100-day average). Its news tone weighs on it most (-7.5 points: average FinBERT sentiment +0.200 over 21 articles). Our research found no proven record of these factors predicting returns.

How the score is built

Trend: 69/100 (+3.7 points)

1. Price is +4.0% vs its 100-day average → higher than 53% of the comparison group → 53
2. 12-1 month momentum +42.0% → higher than 84% of the comparison group → 84
3. Average of the two → trend score 68.7

Tested in our research: the trend rule did not hold up out of sample.

Stability: 57/100 (+1.4 points)

1. Forecast 26.8% vs normal 26.4% → ratio 1.02
2. Ratio is higher than 43% of the comparison group → 100 minus 43 → stability 57.1 (bigger expected swings than usual → lower stability)

A machine-learning volatility model beat HAR for the S&P 500 (p = 0.04); not yet tested on single stocks. This component uses HAR.

Fundamentals: 58/100 (+1.7 points)

1. Revenue growth vs a year earlier: +4.2% → higher than 23% of the comparison group → 23
2. Operating-margin change vs a year earlier: not available
3. Change in leverage (1 - equity/assets) vs a year earlier: -7.1 pp → higher than 94% of the comparison group (lower is better) → 94
4. Average of available items → fundamentals score 58.5

Not yet tested in our research.

Market backdrop: 51/100 (+0.2 points)

1. VIX in its 5-year range: 60 after inverting (lower VIX → higher)
2. Breadth vs its 5-year range → 45
3. Credit trend vs its 5-year range → 15
4. Yield curve vs its 5-year range → 83
5. Average → backdrop score 50.8 (same for every stock)

Tested in our research: cross-asset indicators did not improve forecasts.

News tone: 12/100 (-7.5 points)

1. Average FinBERT sentiment +0.200 over 21 articles; shrunk towards 0 for few articles → tone +0.161
2. Tone vs this stock's own past year → news score 12.5

Tested in our research: news sentiment made predictions slightly worse.

BMY score history (weekly)

Health care stocks compared

• ABBV: 62/100
• AMGN: 62/100
• LLY: 60/100
• MMM: 59/100
• BIIB: 58/100
• GILD: 54/100
• PFE: 50/100
• BMY: 50/100
• UNH: 49/100
• MDT: 48/100
• MRK: 37/100
• ABT: 36/100
• JNJ: 36/100

Questions

What is Bristol Myers Squibb Co's (BMY) Quantooo score today?

BMY scores 50 out of 100 on 2026-10-22, around average among 99 US stocks. It ranks 47th of 99 overall and 8th of 13 in Health care. It was 43 a week earlier.

What raises and lowers BMY's score?

Trend adds the most (69/100, +3.7 points) and news tone weighs on it most (12/100, -7.5 points). The score is 50 plus each part's weighted distance from 50.

Is BMY stock volatile right now?

Our volatility model (HAR) expects annualised swings of 26.8% over the next 20 trading days, against a normal level of 26.4% for BMY: about as calm as usual for this stock. Its stability score is 57/100 compared with the other 99 US stocks.

How are Bristol Myers Squibb Co's fundamentals changing?

Revenue growth vs a year earlier: +4.2%; Operating-margin change vs a year earlier: not available; Change in leverage (1 - equity/assets) vs a year earlier: -7.1 pp. Fundamentals score: 58/100. From the 10-Q filed 2026-07-30 (period to 2026-06-30).

Does the score predict BMY's share price?

No. The score describes the stock's recent data; it is not a forecast of the share price. Our own tests found no reliable ability to rank stocks by future returns, and every test, including the failures, is published. Educational, not investment advice.

Sector: Health care. Data as of 2026-10-22. Scores describe data; they are not recommendations or predictions. Educational, not investment advice.